Physician profile
Larry Ferdinand
NPI 1255599601
$3,959.71
in general payments reported to CMS, 2019-2025
12 companies · $1,766 in 2025
The $1,766 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $16.99 · 2021: $156 · 2022: $194 · 2023: $159 · 2024: $1,562 · 2025: $1,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,173 · Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,172.87 |
| Food and Beverage | $1,314.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,680.08 | 2019-2025 | Lensx, Clareon Panoptix Pro, Unity |
| Bausch & Lomb Americas INC. | $1,388.50 | 2025 | |
| Glaukos Corporation | $156.14 | 2020-2025 | Idosetr |
| Sun Pharmaceutical Industries INC. | $150.00 | 2024 | |
| Genentech USA, INC. | $146.25 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $145.34 | 2021-2024 | Tecnis Simplicity |
| Allergan, INC. | $113.35 | 2021 | |
| Rayner Intraocular Lenses Limited | $49.72 | 2023 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Apellis Pharmaceuticals, INC. | $48.07 | 2023 | |
| Oyster Point Pharma, INC. | $30.71 | 2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $28.33 | 2025 | Xdemvy |
| Abbvie INC. | $23.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Ferdinand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.